Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Drug Testing for Pain Management LabCorp MedWatch SM Prescription Drug Monitoring for Patients who are Prescribed Pain Medications LabCorp offers pain management drug testing profiles that provide physicians with information relevant to the treatment of patients who are prescribed pain medications. LabCorp pain management drug tests can assist in monitoring patients and help detect prescription drug diversion. Clinical Application Customer Support LabCorp provides support staff specifically trained to assist pain management drug testing accounts. The support staff is available through a dedicated toll-free number or e-mail, 888-883-5017 or [email protected]. Innovative Information Technology Solutions LabCorp offers innovative information technology solutions to meet specific program management needs. Multiple connectivity options provide customers with secure access to result information. To assist in identifying potentially dangerous drug interactions, LabCorp’s pain management drug test profiles include both illicit and prescription drugs. Pain management drug testing is performed at levels appropriate for drugs prescribed in pain treatment, which are lower than levels typically used in workplace testing. LabCorp’s pain management profiles include specimen validity testing to identify dilute, adulterated, or substituted specimens that may affect test results. eLabCorp offers: Simple on-line ordering Order management and tracking On-demand result printing Exceptional Service Patient Services Toxicology Technical Assistance LabCorp provides a toll-free telephone line for physicians and their staff to obtain pain management drug testing technical assistance, 888-883-5017. Senior technical staff are available during regular business hours. Technical assistance requests may also be submitted via e-mail to [email protected], and a telephone response will be provided. • • • Additional connectivity options: • Electronic data interchange • Automatic faxing of results LabCorp accepts most insurance plans and provides insurance billing where allowed. LabCorp’s billing systems have the flexibility to offer either account or patient billing to meet varying pain management program needs. For patient convenience, specimen collections are available through many of LabCorp’s more than 1600 patient service centers (PSCs) located throughout the US. Contact your LabCorp representative today to implement pain management drug testing in your practice, or contact us at 888-883-5017. Drug Testing for Pain Management LabCorp MedWatch Pain Management Profiles SM Screening Profiles Screening and Confirmation Profiles Test Name Test Nº CPT Components Pain Management Profile, 10 Drugs, Urine (PMP-10)A 737588 80101(x10) Amphetamines (amphetamine, methamphetamine); barbiturates (amobarbital, butalbital, phenobarbital, pentobarbital, secobarbital); benzodiazepines/metabolites* (alprazolam metabolite, flurazepam metabolite, nordiazepam, oxazepam, temazepam, triazolam metabolite); cannabinoid metabolite (marijuana/THC); cocaine (as benzoyleconine); methadone; opiates (codeine, morphine, hydrocodone, hydromorphone); oxycodone/oxymorphone; phencyclidine (PCP); propoxyphene/ metabolite; specimen validity testing: creatinine, specific gravity (if creatinine is <20 mg/dL), and pH; confirmation of initial test positive by GC/MS at an additional charge Pain Management Profile, 13 Drugs, Urine (PMP-13)A 763824 80101(x13)C Amphetamines (amphetamine, methamphetamine); barbiturates (amobarbital, butalbital, phenobarbital, pentobarbital, secobarbital); benzodiazepines/metabolites* (alprazolam metabolite, flurazepam metabolite, nordiazepam, oxazepam, temazepam, triazolam metabolite); cannabinoid metabolite (marijuana/THC); cocaine (as benzoyleconine); fentanyl; meperidine/metabolite; methadone; opiates (codeine, morphine, hydrocodone, hydromorphone); oxycodone/oxymorphone; phencyclidine (PCP); propoxyphene/metabolite; tramadol; specimen validity testing: creatinine, specific gravity (if creatinine is <20 mg/dL), and pH; confirmation of initial test positive by GC/MS at an additional charge Pain Management Screening Profile, 10 Drugs, Urine (PMP-10S)B 733692 80101(x10)C Amphetamine; barbiturate; benzodiazepines; cannabinoid; cocaine; methadone; opiates; oxycodone/oxymorphone; phencyclidine; propoxyphene; specimen validity testing: creatinine, specific gravity (if creatinine is <20 mg/dL), and pH Pain Management Screening Profile, 11 Drugs, Urine (PMP-11S)B 733727 80101(x11)C Amphetamine; barbiturate; benzodiazepines; buprenorphine; cannabinoid; cocaine; methadone; opiates; oxycodone/oxymorphone; phencyclidine; propoxyphene; specimen validity testing: creatinine, specific gravity (if creatinine is <20 mg/dL), and pH Pain Management Screening Profile, 13 Drugs, Urine (PMP-13S)B 733690 80101(x13)C Amphetamine; barbiturate; benzodiazepines; cannabinoid; cocaine; fentanyl; meperidine; methadone; opiates; oxycodone/oxymorphone; phencyclidine; propoxyphene; tramadol; specimen validity testing: creatinine, specific gravity (if creatinine is <20 mg/dL), and pH Pain Management Screening Profile, 14 Drugs, Urine (PMP-14S)B 733726 80101(x14)C Amphetamine; barbiturate; benzodiazepines; buprenorphine; cannabinoid; cocaine; fentanyl; meperidine; methadone; opiates; oxycodone/oxymorphone; phencyclidine; propoxyphene; tramadol; specimen validity testing: creatinine, specific gravity (if creatinine is <20 mg/dL), and pH C Specimen Requirement Specimen Urine (random) Volume 50 mL Container Urine container Storage Instructions Maintain specimen at room temperature. If arrival at the lab extends beyond seven days, then refrigerate. A Methodology Initial test by immunoassay; confirmation of initial test positives by gas chromatography/mass spectrometry (GC/MS) or liquid chromatography tandem mass spectrometry (LC/MS/MS) B Methodology Immunoassay; confirmation testing may be added by contacting LabCorp. C If confirmation is performed an additional fee will be charged. Additional drugs are available on request to meet the specific needs of varying pain management programs. Quantitative levels are provided for most confirmed positive drug results. *Clonazepam (Clonopin®) and/or lorazepam (Ativan®) may be detected at higher concentrations (>3000 ng/mL); for patients prescribed these drugs test 763910 is also recommended. Specialty Tests Pharmacogenetics LabCorp offers cytochrome P450 (2D6, 2C19) genetic testing that can be useful in identifying individuals who may have an adverse drug reaction or a poor response to medication based on specific genotypes of these drug metabolizing enzymes. Certain variants of cytochrome P450 alter the rate of drug metabolism and may cause increased or decreased drug efficacy or adverse drug reactions. For more information, please view our Test Menu at www.LabCorp.com. Serum Drug Monitoring To assist physicians in providing comprehensive care for patients receiving pain medications, LabCorp offers a full menu of clinical and esoteric tests. Available tests include serum drug monitoring for commonly prescribed anticonvulsants, antidepressants, antipsychotics, anxiolytics, muscle relaxants, and narcotics that may be prescribed in conjunction with pain therapy. For more information, or to set up a pain management drug testing program, contact us at [email protected] or 888-883-5017. ©2011 Laboratory Corporation of America® Holdings All rights reserved. L5646-1211-7